176 related articles for article (PubMed ID: 17445796)
1. Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine in anesthetized dogs.
Takahara A; Iwasaki H; Nakamura Y; Sugiyama A
Eur J Pharmacol; 2007 Jun; 565(1-3):166-70. PubMed ID: 17445796
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.
Nap A; Mathy MJ; Balt JC; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2004 Jun; 18(3):309-19. PubMed ID: 15147282
[TBL] [Abstract][Full Text] [Related]
3. Cilnidipine, an N+L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction.
Nagai H; Minatoguchi S; Chen XH; Wang N; Arai M; Uno Y; Lu C; Misao Y; Onogi H; Kobayashi H; Takemura G; Maruyama R; Fujiwara T; Fujiwara H
Hypertens Res; 2005 Apr; 28(4):361-8. PubMed ID: 16138567
[TBL] [Abstract][Full Text] [Related]
4. Effects of a dual L/N-type Ca(2+) channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs.
Konda T; Takahara A; Maeda K; Dohmoto H; Yoshimoto R
Eur J Pharmacol; 2001 Feb; 413(1):117-20. PubMed ID: 11173070
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of an L- and N-type calcium channel blocker in hypertensive patients with neurovascular compression of the rostral ventrolateral medulla.
Aota Y; Morimoto S; Sakuma T; Morita T; Jo F; Takahashi N; Maehara M; Ikeda K; Sawada S; Iwasaka T
Hypertens Res; 2009 Aug; 32(8):700-5. PubMed ID: 19521420
[TBL] [Abstract][Full Text] [Related]
6. L/N-type calcium channel blocker suppresses reflex aldosterone production induced by antihypertensive action.
Aritomi S; Konda T; Yoshimura M
Heart Vessels; 2012 Jul; 27(4):419-23. PubMed ID: 21989861
[TBL] [Abstract][Full Text] [Related]
7. Chronotropic effects of azelnidipine, a slow- and long-acting dihydropyridine-type calcium channel blocker, in anesthetized dogs: a comparison with amlodipine.
Fujisawa M; Yorikane R; Chiba S; Koike H
J Cardiovasc Pharmacol; 2009 Apr; 53(4):325-32. PubMed ID: 19295444
[TBL] [Abstract][Full Text] [Related]
8. Comparison of anti-anginal effect of cilnidipine with those of nicardipine and nifedipine in the vasopressin-induced angina model of rats.
Cao X; Nakamura Y; Wada T; Izumi-Nakaseko H; Ando K; Zhu B; Xu B; Takahara A; Saitoh M; Sugiyama A
Heart Vessels; 2016 Dec; 31(12):2045-2052. PubMed ID: 27194426
[TBL] [Abstract][Full Text] [Related]
9. Antisympathetic and hemodynamic property of a dual L/N-type Ca(2+) channel blocker cilnidipine in rats.
Takahara A; Koganei H; Takeda T; Iwata S
Eur J Pharmacol; 2002 Jan; 434(1-2):43-7. PubMed ID: 11755164
[TBL] [Abstract][Full Text] [Related]
10. Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm.
Konda T; Enomoto A; Aritomi S; Niinuma K; Koganei H; Ogawa T; Nitta K
Am J Nephrol; 2009; 30(2):155-61. PubMed ID: 19325231
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the cardioprotective and renoprotective effects of the L/N-type calcium channel blocker, cilnidipine, in adriamycin-treated spontaneously-hypertensive rats.
Aritomi S; Harada E; Sugino K; Nishimura M; Nakamura T; Takahara A
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):344-52. PubMed ID: 25582553
[TBL] [Abstract][Full Text] [Related]
12. An N-/L-type calcium channel blocker, cilnidipine, suppresses autonomic, electrical, and structural remodelling associated with atrial fibrillation.
Tajiri K; Guichard JB; Qi X; Xiong F; Naud P; Tardif JC; Costa AD; Aonuma K; Nattel S
Cardiovasc Res; 2019 Dec; 115(14):1975-1985. PubMed ID: 31119260
[TBL] [Abstract][Full Text] [Related]
13. Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Nako H; Ogawa H; Kim-Mitsuyama S
J Hypertens; 2010 Jun; 28(6):1321-9. PubMed ID: 20224431
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the inhibitory effect of dihydropyridines on N-type calcium channel by virtual three-dimensional pharmacophore modeling.
Ogihara T; Kano T; Kakinuma C
Arzneimittelforschung; 2009; 59(6):283-8. PubMed ID: 19634509
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
Yamada Y; Kinoshita H; Kuwahara K; Nakagawa Y; Kuwabara Y; Minami T; Yamada C; Shibata J; Nakao K; Cho K; Arai Y; Yasuno S; Nishikimi T; Ueshima K; Kamakura S; Nishida M; Kiyonaka S; Mori Y; Kimura T; Kangawa K; Nakao K
Cardiovasc Res; 2014 Oct; 104(1):183-93. PubMed ID: 25100767
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of an L/N-type Ca2+ channel blocker cilnidipine assessed in the chronic atrioventricular conduction block dogs.
Takahara A; Sugiyama A; Satoh Y; Nakamura Y; Hashimoto K
J Pharmacol Sci; 2004 Oct; 96(2):219-23. PubMed ID: 15492462
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
Yamamoto T; Niwa S; Ohno S; Onishi T; Matsueda H; Koganei H; Uneyama H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
Bioorg Med Chem Lett; 2006 Feb; 16(4):798-802. PubMed ID: 16309909
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of L- and N-type calcium channel blocker on glucose and lipid metabolism and renal function in patients with hypertension and type II diabetes mellitus.
Masuda T; Ogura MN; Moriya T; Takahira N; Matsumoto T; Kutsuna T; Hara M; Aiba N; Noda C; Izumi T
Cardiovasc Ther; 2011 Feb; 29(1):46-53. PubMed ID: 20337636
[TBL] [Abstract][Full Text] [Related]
20. Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release.
Takahara A
Cardiovasc Ther; 2009; 27(2):124-39. PubMed ID: 19426250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
